Professor of Pharmacometrics
Uppsala University
Uppsala, Sweden
Andrew C. Hooker, PhD, is a Professor of Pharmacometrics at Uppsala University, Sweden. Andrew received a BS in Physics with a Mathematics Minor at the University of Colorado and received a Masters and then a PhD in Bioengineering from the University of Washington, Seattle. Andrew joined the faculty at Uppsala University in 2006. His research ranges between methodological and applied pharmacometrics, including: optimal (adaptive) experimental design, methodological problems associated with building, evaluating and using pharmacometric models (including using models for bioequivalence evaluation) and the development and use of PKPD models in a range of therapeutic areas and drug classes. Andrew is a co-developer of a number of software programs including Xpose, PsN, Pharmpy and the optimal design program PopED. Andrew has published over 90 papers in peer reviewed journals, supervised 12 students to their PhD degree and mentored 11 post-docs. In 2012, he co-founded the model-informed drug development consultancy company Pharmetheus.
Disclosure(s): Pharmetheus AB: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Tuesday, November 12, 2024
2:00 PM – 3:30 PM MST
Development of A User-Friendly Platform for Model-Integrated Bioequivalence Analysis
Tuesday, November 12, 2024
2:30 PM – 3:00 PM MST
Challenges in characterizing treatment response in oncology - Pitfalls and solutions
Wednesday, November 13, 2024
9:00 AM – 10:30 AM MST
The flawed assumption of proportional hazards in oncology studies - What are the alternatives?
Wednesday, November 13, 2024
9:30 AM – 10:00 AM MST